Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,p53 transcriptional gene network WP4963,0.0026337059130793978,30.42948717948718,180.73178037167722,"['DRAM1', 'SERPINE1']",0.05648741750824253,0,0,2
2,Oncostatin M Signaling Pathway WP2374,0.00374359394931819,25.22872340425532,140.97076936452996,"['PRKCH', 'SERPINE1']",0.05648741750824253,0,0,2
3,Blood Clotting Cascade WP272,0.0037658278338828354,560.7058823529412,3129.7411221337325,['SERPINE1'],0.05648741750824253,0,0,1
4,Pathways Regulating Hippo Signaling WP4540,0.005565878004848145,20.420258620689655,106.0036154311027,"['FLT1', 'PRKCH']",0.06261612755454163,0,0,2
5,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.00938950596004719,140.13235294117646,654.1606091284186,['CHI3L1'],0.07822936478468281,0,0,1
6,Gastrin signaling pathway WP4659,0.010430581971291042,14.58641975308642,66.55802607395717,"['PRKCH', 'SERPINE1']",0.07822936478468281,0,0,2
7,RAS and bradykinin pathways in COVID-19 WP4969,0.016841134119378494,70.03676470588235,286.0253093168708,['SERPINE1'],0.0966440788202526,0,0,1
8,Ras signaling WP4223,0.01939030564295849,10.420353982300885,41.087268674919194,"['FLT1', 'RASAL3']",0.0966440788202526,0,0,2
9,TP53 network WP1742,0.020547069274251675,56.01764705882353,217.63062938151919,['TNFSF10'],0.0966440788202526,0,0,1
10,Imatinib and Chronic Myeloid Leukemia WP3640,0.0223950862468196,50.919786096256686,193.43987341796063,['FLT1'],0.0966440788202526,0,0,1
11,Angiogenesis WP1539,0.027919400548072973,39.99579831932773,143.12230343163242,['FLT1'],0.0966440788202526,0,0,1
12,Vitamin B12 metabolism WP1533,0.027919400548072973,39.99579831932773,143.12230343163242,['SERPINE1'],0.0966440788202526,0,0,1
13,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.027919400548072973,39.99579831932773,143.12230343163242,['SERPINE1'],0.0966440788202526,0,0,1
14,miRNA regulation of p53 pathway in prostate cancer WP3982,0.033414224976825176,32.92733564013841,111.9125581752901,['SERPINE1'],0.10024267493047553,0,0,1
15,Complement and Coagulation Cascades WP558,0.033414224976825176,32.92733564013841,111.9125581752901,['SERPINE1'],0.10024267493047553,0,0,1
16,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.042507133418739414,25.43048128342246,80.31158008286354,['SERPINE1'],0.1135043019041226,0,0,1
17,Folate Metabolism WP176,0.046121627527350446,23.306372549019606,71.7014327558044,['SERPINE1'],0.1135043019041226,0,0,1
18,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.04792403858174066,22.371764705882352,67.96850962417851,['NOD1'],0.1135043019041226,0,0,1
19,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.04792403858174066,22.371764705882352,67.96850962417851,['PRKCH'],0.1135043019041226,0,0,1
20,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.05688794978623248,18.633333333333333,53.41565007150507,['TNFSF10'],0.1200091518148276,0,0,1
21,TGF-beta Receptor Signaling WP560,0.05688794978623248,18.633333333333333,53.41565007150507,['SERPINE1'],0.1200091518148276,0,0,1
22,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.05867114088724905,18.0303605313093,51.130628203772666,['LIMD1'],0.1200091518148276,0,0,1
23,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.06400162841077368,16.43425605536332,45.17525137977895,['SERPINE1'],0.12522057732542677,0,0,1
24,Rett syndrome causing genes WP4312,0.07106461080078696,14.698142414860682,38.86432556262482,['CECR2'],0.13324614525147555,0,0,1
25,Selenium Micronutrient Network WP15,0.07457719724068766,13.96029411764706,36.23981348378686,['SERPINE1'],0.1342389550332378,0,0,1
26,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.0780772369537577,13.292717086834735,33.89718259918996,['PRKCH'],0.13513367934304218,0,0,1
27,Apoptosis WP254,0.0936732776670095,10.936562860438293,25.89715004058118,['TNFSF10'],0.14854346141645466,0,0,1
28,Osteoblast differentiation WP4787,0.09710506073592705,10.521642619311876,24.53606851669251,['PRKCH'],0.14854346141645466,0,0,1
29,Apoptosis Modulation and Signaling WP1772,0.10052456886056214,10.136898395721925,23.288035106719676,['TNFSF10'],0.14854346141645466,0,0,1
30,Pathways in clear cell renal cell carcinoma WP4018,0.10222973274146371,9.954831932773109,22.702319909981846,['FLT1'],0.14854346141645466,0,0,1
31,Wnt signaling pathway and pluripotency WP399,0.10393184336935753,9.779153766769866,22.140199191726346,['PRKCH'],0.14854346141645466,0,0,1
32,Prolactin Signaling Pathway WP2037,0.10563090589614553,9.609533468559837,21.600350469601395,['CTSD'],0.14854346141645466,0,0,1
33,Hippo-Merlin Signaling Dysregulation WP4541,0.11070985618489373,9.13404050144648,20.10258369322476,['FLT1'],0.14876044092629964,0,0,1
34,Glioblastoma signaling pathways WP2261,0.11239677758875974,8.985768500948767,19.64037402739012,['PRKCH'],0.14876044092629964,0,0,1
35,Adipogenesis WP236,0.11576155799915763,8.703125,18.765876015579785,['SERPINE1'],0.14883628885605982,0,0,1
36,Senescence and Autophagy in Cancer WP615,0.11911428914801112,8.437611408199643,17.95246813746884,['SERPINE1'],0.1488928614350139,0,0,1
37,G Protein Signaling Pathways WP35,0.125783766000802,7.952100840336135,16.486223806929537,['PRKCH'],0.15298025594692133,0,0,1
38,Myometrial relaxation and contraction pathways WP289,0.1663996919833129,5.843962848297213,10.48034441761828,['PRKCH'],0.1956585862273689,0,0,1
39,Calcium Regulation in the Cardiac Cell WP536,0.1695707747303864,5.722255912674348,10.154056649631533,['PRKCH'],0.1956585862273689,0,0,1
40,Focal Adhesion WP306,0.18525602835392888,5.181968114348543,8.736883606533072,['FLT1'],0.20841303189816998,0,0,1
41,Circadian rhythm related genes WP3594,0.19606876444775442,4.860165118679051,7.918617659580265,['SERPINE1'],0.21519742439387682,0,0,1
42,Insulin Signaling WP481,0.2112806562007318,4.463472485768501,6.938771071956038,['PRKCH'],0.2263721316436412,0,0,1
43,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.25387259775897936,3.606305267204921,4.943965831205206,['FLT1'],0.26401957229677464,0,0,1
44,PI3K-Akt signaling pathway WP4172,0.25815247069017966,3.5358220211161386,4.78822749573256,['FLT1'],0.26401957229677464,0,0,1
45,VEGFA-VEGFR2 Signaling Pathway WP3888,0.4640577064378429,1.6719317356572259,1.2836195162002446,['FLT1'],0.4640577064378429,0,0,1
